Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

NCT07444632 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lymphoid
Hodgkin Lymphoma

Interventions

DRUG: Fludarabine
DRUG: TGFBR2 KO CAR27/IL-15 NK cells
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center